Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
Katharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
Cellular & Molecular Immunology
|
January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Stéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.
Science Translational Medicine
|
January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Benjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Science Translational Medicine
|
July 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates
Prabhu S Arunachalam, NaYoung Ha, S Moses Dennison, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2
Yupeng Feng, Meng Yuan, John M Powers, et al.
Elife
|
October 14, 2022
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Immunity
|
March 30, 2023
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S Arunachalam, et al.
Science Translational Medicine
|
May 10, 2023
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M Powers, et al.
NPJ Vaccines
|
May 23, 2022
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Lilit Grigoryan, Audrey Lee, Alexandra C Walls, et al.
Cell Reports
|
August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Alexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
Katharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
Cellular & Molecular Immunology
|
January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Stéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.
Science Translational Medicine
|
January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Benjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Science Translational Medicine
|
July 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates
Prabhu S Arunachalam, NaYoung Ha, S Moses Dennison, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2
Yupeng Feng, Meng Yuan, John M Powers, et al.
Elife
|
October 14, 2022
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Immunity
|
March 30, 2023
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S Arunachalam, et al.
Science Translational Medicine
|
May 10, 2023
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M Powers, et al.
NPJ Vaccines
|
May 23, 2022
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Lilit Grigoryan, Audrey Lee, Alexandra C Walls, et al.
Cell Reports
|
August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Alexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Page
of 8